Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant Recipients
Lode J. Swinnen(Palmetto Hematology Oncology), Maria Rosa Costanzo‐Nordin, Susan G. Fisher, E. Jeanne O'Sullivan, Maryl R. Johnson, Alain Heroux, George J. Dizikes, R Pifarré, Richard I. Fisher(Palmetto Hematology Oncology)
Cited by 952
Abstract
A sudden increase in the incidence of post-transplantation lymphoproliferative disorder among the patients in our cardiac-transplantation program was temporally related to introduction of the immunosuppressive drug OKT3. This monoclonal antibody has come to be widely used in recent years both to prevent and to treat rejection after cardiac transplantation.
Related Papers
No related papers found
Powered by citation graph analysis